Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hemophagocytic lymphohistiocytosis
Comorbidity C0023290|visceral leishmaniasis
Sentences 8
PubMedID- 25768375 Tocilizumab as an adjuvant therapy for hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis.
PubMedID- 23324220 hemophagocytic lymphohistiocytosis associated with visceral leishmaniasis in late adulthood.
PubMedID- 23511497 hemophagocytic lymphohistiocytosis (hlh) associated with visceral leishmaniasis (vl) is a very rare phenomenon.
PubMedID- 24076317 [infantile visceral leishmaniasis, an etiology of easily curable hemophagocytic lymphohistiocytosis syndrome].
PubMedID- 23815374 visceral leishmaniasis with haemophagocytic lymphohistiocytosis: the importance of scrutinising your samples.
PubMedID- 20880678 [treatment of severe hemophagocytic syndrome associated with visceral leishmaniasis].
PubMedID- 22080147 hemophagocytic syndrome associated with visceral leishmaniasis in an immunocompetent adult-case report and review of the literature.
PubMedID- 25970110 hemophagocytic lymphohistiocytosis in children with visceral leishmaniasis.

Page: 1